Insight into Crosstalk Between Mitophagy and Apoptosis/Necroptosis: Mechanisms and Clinical Applications in Ischemic Stroke

Abstract

Ischemic stroke is a serious cerebrovascular disease with high morbidity and mortality. As a result of ischemia-reperfusion, a cascade of pathophysiological responses is triggered by the imbalance in metabolic supply and demand, resulting in cell loss. These cellular injuries follow various molecular mechanisms solely or in combination with this disorder. Mitochondria play a driving role in the pathophysiological processes of ischemic stroke. Once ischemic stroke occurs, damaged cells would respond to such stress through mitophagy. Mitophagy is known as a conservatively selective autophagy, contributing to the removal of excessive protein aggregates and damaged intracellular components, as well as aging mitochondria. Moderate mitophagy may exert neuroprotection against stroke. Several pathways associated with the mitochondrial network collectively contribute to recovering the homeostasis of the neurovascular unit. However, excessive mitophagy would also promote ischemia-reperfusion injury. Therefore, mitophagy is a double-edged sword, which suggests that maximizing the benefits of mitophagy is one of the direction of future efforts. This review emphasized the role of mitophagy in ischemic stroke, and highlighted the crosstalk between mitophagy and apoptosis/necroptosis.

Keywords

mitophagy / ischemic stroke / apoptosis / necroptosis / clinical application / crosstalk

References

[1] BenjaminEJ, MuntnerP, AlonsoA, et al.. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation, 2019, 139(10): e56-e528

[2] LakhanSE, KirchgessnerA, HoferM. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med, 2009, 7: 97

[3] BarthelsD, DasH. Current advances in ischemic stroke research and therapies. Biochimi Biophys Acta Mol Basis Dis, 2020, 1866(4): 165260

[4] National Institute of Neurological DisordersStroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333(24): 1581-1587

[5] GoyalM, DemchukAM, MenonBK, et al.. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med, 2015, 372(11): 1019-1030

[6] ChenW, HuangJJ, HuYQ, et al.. Mitochondrial Transfer as a Therapeutic Strategy Against Ischemic Stroke. Transl Stroke Res, 2020, 11(6): 1214-1228

[7] MayevskyA, Kutai-AsisH, TolmasovM. Mitochondrial function and brain Metabolic Score (BMS) in ischemic Stroke: Evaluation of “neuroprotectants” safety and efficacy. Mitochondrion, 2020, 50: 170-194

[8] HuHZ, FengXB, ShaoZW, et al.. Application and Prospect of Mixed Reality Technology in Medical Field. Curr Med Sci, 2019, 39(1): 1-6

[9] LipGYH, NieuwlaatR, PistersR, et al.. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation. Chest, 2010, 137(2): 263-272

[10] HackeW, KasteM, BluhmkiE, et al.. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 2008, 359(13): 1317-1329

[11] RabinsteinAA. Update on Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn), 2020, 26(2): 268-286

[12] ZhangD, ZouX, SyC, et al.. Thrombolysis and reperfusion: advanced understanding of early management strategies in acute ischemic stroke. Neurol Res, 2014, 36(5): 391-396

[13] CagalinecM, SafiulinaD, LiivM, et al.. Principles of the mitochondrial fusion and fission cycle in neurons. J Cell Sci, 2013, 126: 2187-2197(Pt 10)

[14] ChanPH. Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann N Y Acad Sci, 2005, 1042: 203-209

[15] CorreaF, SotoV, ZazuetaC. Mitochondrial permeability transition relevance for apoptotic triggering in the post-ischemic heart. Int J Biochem Cell Biol, 2007, 39(4): 787-798

[16] CarinciM, VezzaniB, PatergnaniS, et al.. Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion. Biomedicines, 2021, 9(2): 169

[17] WangL, QiH, TangY, et al.. Post-translational Modifications of Key Machinery in the Control of Mitophagy. Trends Biochem Sci, 2020, 45(1): 58-75

[18] LiX, HuangL, LanJ, et al.. Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases. Pharmacol Res, 2021, 163: 105240

[19] BingolB, ShengM. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Free Radic Biol Med, 2016, 100: 210-222

[20] LuW, SunJ, YoonJS, et al.. Mitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis. PLoS One, 2016, 11(1): e0147792

[21] ShenL, GanQ, YangY, et al.. Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury. Front Aging Neurosci, 2021, 13: 687246

[22] KapadiaM, De SnooML, KaliaLV, et al.. Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members. Neural Regen Res, 2021, 16(4): 684-685

[23] FilippovMA, TatarnikovaOG, PozdnyakovaNV, et al.. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls. Neural Regen Res, 2021, 16(2): 223-233

[24] ParkHA, BromanK, JonasEA. Oxidative stress battles neuronal Bcl-xL in a fight to the death. Neural Regen Res, 2021, 16(1): 12-15

[25] OttM, RobertsonJD, GogvadzeV, et al.. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA, 2002, 99(3): 1259-1263

[26] BaechlerBL, BloembergD, QuadrilateroJ. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy, 2019, 15(9): 1606-1619

[27] CenX, ChenY, XuX, et al.. Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model. Nat Commun, 2020, 11(1): 5731

[28] KangL, LiuS, LiJ, et al.. Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses. Life Sci, 2020, 243: 117244

[29] ErustesAG, D’ElettoM, GuaracheGC, et al.. Overexpression of alpha-synuclein inhibits mitoch-ondrial Ca(2+) trafficking between the endoplasmic reticulum and mitochondria through MAMs by altering the GRP75-IP3R interaction. J Neurosci Res, 2021, 99(11): 2932-2947

[30] YooSM, JungYK. A Molecular Approach to Mitophagy and Mitochondrial Dynamics. Mol Cells, 2018, 41(1): 18-26

[31] RobertsRF, TangMY, FonEA, et al.. Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles. Int J Biochem Cell Biol, 2016, 79: 427-436

[32] NarendraD, TanakaA, SuenDF, et al.. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 2008, 183(5): 795-803

[33] NarendraDP, JinSM, TanakaA, et al.. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol, 2010, 8(1): e1000298

[34] LazarouM, JinSM, KaneLA, et al.. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell, 2012, 22(2): 320-333

[35] DeasE, Plun-FavreauH, GandhiS, et al.. PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet, 2011, 20(5): 867-879

[36] SekineS. PINK1 import regulation at a crossroad of mitochondrial fate: the molecular mechanisms of PINK1 import. J Biochem, 2020, 167(3): 217-224

[37] OkatsuK, OkaT, IguchiM, et al.. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat Commun, 2012, 3: 1016

[38] Zhang T, Liu Q, Gao W, et al. The multifaceted regulation of mitophagy by endogenous metabolites. Autophagy, 2021,1–24

[39] NiHM, WilliamsJA, DingWX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol, 2015, 4: 6-13

[40] YamadaT, DawsonTM, YanagawaT, et al.. SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy. Autophagy, 2019, 15(11): 2012-2018

[41] YamanoK, MatsudaN, TanakaK. The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation. EMBO Rep, 2016, 17(3): 300-316

[42] YamanoK, QueliconiBB, KoyanoF, et al.. Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation. J Biol Chem, 2015, 290(42): 25199-25211

[43] PooleAC, ThomasRE, YuS, et al.. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One, 2010, 5(4): e10054

[44] WangX, WinterD, AshrafiG, et al.. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell, 2011, 147(4): 893-906

[45] SarrafSA, RamanM, Guarani-PereiraV, et al.. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature, 2013, 496(7445): 372-376

[46] KoyanoF, YamanoK, KosakoH, et al.. Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL. J Biol Chem, 2019, 294(26): 10300-10314

[47] MatsudaN, YamanoK. Two sides of a coin: Physiological significance and molecular mechanisms for damage-induced mitochondrial localization of PINK1 and Parkin. Neurosci Res, 2020, 159: 16-24

[48] Hamacher-BradyA, BradyNR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci, 2016, 73(4): 775-795

[49] ChenG, CizeauJ, Vande VeldeC, et al.. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem, 1999, 274(1): 7-10

[50] BellotG, Garcia-MedinaR, GounonP, et al.. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol, 2009, 29(10): 2570-2581

[51] ChoiGE, LeeHJ, ChaeCW, et al.. BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat Commun, 2021, 12(1): 487

[52] LeiL, YangS, LuX, et al.. Research Progress on the Mechanism of Mitochondrial Autophagy in Cerebral Stroke. Front Aging Neurosci, 2021, 13: 698601

[53] KuangY, MaK, ZhouC, et al.. Structural basis for the phosphorylation of FUNDC1 LIR as a molecular switch of mitophagy. Autophagy, 2016, 12(12): 2363-2373

[54] CaiY, YangE, YaoX, et al.. FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury. Redox Biol, 2021, 38: 101792

[55] LiuH, ZangC, YuanF, et al.. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases. Biochem Pharmacol, 2022, 197: 114891

[56] LiuL, FengD, ChenG, et al.. Mitochondrial outermembrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol, 2012, 14(2): 177-185

[57] ChenG, HanZ, FengD, et al.. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell, 2014, 54(3): 362-377

[58] SugoM, KimuraH, ArasakiK, et al.. Syntaxin 17 regulates the localization and function of PGAM5 in mitochondrial division and mitophagy. EMBO J, 2018, 37(21): e98899

[59] XinY, ZhangX, LiJ, et al.. New Insights Into the Role of Mitochondria Quality Control in Ischemic Heart Disease. Front Cardiovasc Med, 2021, 8: 774619

[60] NanJ, ZhuW, RahmanMS, et al.. Molecular regulation of mitochondrial dynamics in cardiac disease. Biochim Biophys Acta Mol Cell Res, 2017, 1864(7): 1260-1273

[61] AnzellAR, FogoGM, GurmZ, et al.. Mitochondrial fission and mitophagy are independent mechanisms regulating ischemia/reperfusion injury in primary neurons. Cell Death Dis, 2021, 12(5): 475

[62] JiaJ, JinH, NanD, et al.. New insights into targeting mitochondria in ischemic injury. Apoptosis, 2021, 26(3–4): 163-183

[63] ZuoW, ZhangS, XiaCY, et al.. Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner: the role of inhibition of Drp1 in ischemic brain damage. Neuropharmacology, 2014, 86: 103-115

[64] ZhouBH, WeiSS, JiaLS, et al.. Drp1/Mff signaling pathway is involved in fluoride-induced abnormal fission of hepatocyte mitochondria in mice. Sci Total Environ, 2020, 725: 138192

[65] LuanY, RenKD, LuanY, et al.. Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases. Front Cardiovasc Med, 2021, 8: 770574

[66] WuP, LiY, ZhuS, et al.. Mdivi-1 Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats, Possibly via Inhibition of Drp1-Activated Mitochondrial Fission and Oxidative Stress. Neurochem Res, 2017, 42(5): 1449-1458

[67] SmithG, GalloG. To mdivi-1 or not to mdivi-1: Is that the question?. Dev Neurobiol, 2017, 77(11): 1260-1268

[68] FlippoKH, GnanasekaranA, PerkinsGA, et al.. AKAP1 Protects from Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission. J Neurosci, 2018, 38(38): 8233-8242

[69] LaiY, LinP, ChenM, et al.. Restoration of L-OPA1 alleviates acute ischemic stroke injury in rats via inhibiting neuronal apoptosis and preserving mitochondrial function. Redox Biol, 2020, 34: 101503

[70] ZengKW, WangJK, WangLC, et al.. Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity. Signal Transduct Target Ther, 2021, 6(1): 71

[71] PuriR, ChengXT, LinMY, et al.. Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts. Nat Commun, 2019, 10(1): 3645

[72] HamPB3rd, RajuR. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol, 2017, 157: 92-116

[73] SunT, DingW, XuT, et al.. Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D. Antioxid Redox Signal, 2019, 31(16): 1177-1193

[74] NingXJ, YanX, WangYF, et al.. Parkin deficiency elevates hepatic ischemia/reperfusion injury accompanying decreased mitochondrial autophagy, increased apoptosis, impaired DNA damage repair and altered cell cycle distribution. Mol Med Rep, 2018, 18(6): 5663-5668

[75] WangH, ChenS, ZhangY, et al.. Electroacupuncture ameliorates neuronal injury by Pink1/Parkin-mediated mitophagy clearance in cerebral ischemia-reperfusion. Nitric Oxide, 2019, 91: 23-34

[76] ChenJL, WangXX, ChenL, et al.. A sphingosine kinase 2-mimicking TAT-peptide protects neurons against ischemia-reperfusion injury by activating BNIP3-mediated mitophagy. Neuropharmacology, 2020, 181: 108326

[77] YepesM. The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain. Curr Drug Targets, 2019, 20(9): 953-959

[78] JeanneretV, YepesM. Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system. Neural Regen Res, 2017, 12(3): 362-365

[79] ThiebautAM, GaubertiM, AliC, et al.. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. Lancet Neurol, 2018, 17(12): 1121-1132

[80] FengJ, ChenX, GuanB, et al.. Inhibition of Peroxynitrite-Induced Mitophagy Activation Attenuates Cerebral Ischemia-Reperfusion Injury. Mol Neurobiol, 2018, 55(8): 6369-6386

[81] HangY, HeY, Wu, et al.. Rehmapicroside ameliorates cerebral ischemia-reperfusion injury via attenuating peroxynitrite-mediated mitophagy activation. Free Radic Biol Med, 2020, 160: 526-539

[82] ShaoZ, DouS, ZhuJ, et al.. The Role of Mitophagy in Ischemic Stroke. Front Neurol, 2020, 11: 608610

[83] GuanR, ZouW, DaiX, et al.. Mitophagy, a potential therapeutic target for stroke. J Biomed Sci, 2018, 25(1): 87

[84] CainK, BrattonSB, LanglaisC, et al.. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem, 2000, 275(9): 6067-6070

[85] BrattonSB, WalkerG, SrinivasulaSM, et al.. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J, 2001, 20(5): 998-1009

[86] HuXM, LiZX, ZhangDY, et al.. A systematic summary of survival and death signalling during the life of hair follicle stem cells. Stem Cell Res Ther, 2021, 12(1): 453

[87] HuXM, LiZX, LinRH, et al.. Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective. Front Cell Dev Biol, 2021, 9: 634690

[88] YangL, MaYM, ShenXL, et al.. The Involvement of Mitochondrial Biogenesis in Selenium Reduced Hyperglycemia-Aggravated Cerebral Ischemia Injury. Neurochem Res, 2020, 45(8): 1888-1901

[89] DongG, XuN, WangM, et al.. Anthocyanin Extract from Purple Sweet Potato Exacerbate Mitophagy to Ameliorate Pyroptosis in Klebsiella pneumoniae Infection. Int J Mol Sci, 2021, 22(21): 11422

[90] HongT, ZhouY, PengL, et al.. Knocking down peroxiredoxin 6 aggravates cerebral ischemia-reperfusion injury by enhancing mitophagy. Neuroscience, 2021, 482: 30-42

[91] LiY, HuK, LiangM, et al.. Stilbene glycoside upregulates SIRT3/AMPK to promotes neuronal mitochondrial autophagy and inhibit apoptosis in ischemic stroke. Adv Clin Exp Med, 2021, 30(2): 139-146

[92] HeM, ZhangT, FanY, et al.. Deletion of mitochondrial uncoupling protein 2 exacerbates mitophagy and cell apoptosis after cerebral ischemia and reperfusion injury in mice. Int J Med Sci, 2020, 17(17): 2869-2878

[93] MaH, GuoX, CuiS, et al.. Dephosphorylation of AMP-activated kinase exacerbates ischemia/reperfusion-induced acute kidney injury via mitochondrial dysfunction. Kidney Int, 2022, 101(2): 315-330

[94] WuQ, LiuJ, MaoZ, et al.. Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK. Phytomedicine, 2021, 95: 153884

[95] GeislerS, HolmstromKM, SkujatD, et al.. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol, 2010, 12(2): 119-131

[96] YaoGY, ZhuQ, XiaJ, et al.. Ischemic postconditioning confers cerebroprotection by stabilizing VDACs after brain ischemia. Cell Death Dis, 2018, 9(10): 1033

[97] ShiRY, ZhuSH, LiV, et al.. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther, 2014, 20(12): 1045-1055

[98] LimSY, HausenloyDJ, ArjunS, et al.. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J Cell Mol Med, 2011, 15(11): 2443-2451

[99] XuK, LuC, RenX, et al.. Overexpression of HIF-1alpha enhances the protective effect of mitophagy on steroid-induced osteocytes apoptosis. Environ Toxicol, 2021, 36(11): 2123-2137

[100] ShangL, DingW, LiN, et al.. The effects and regulatory mechanism of RIP3 on RGC-5 necroptosis following elevated hydrostatic pressure. Acta Bioch Bioph Sin (Shanghai), 2017, 49(2): 128-137

[101] GuoLM, WangZ, LiSP, et al.. RIP3/MLKL-mediated neuronal necroptosis induced by methamphetamine at 39°C. Neural Regen Res, 2020, 15(5): 865-874

[102] WangZ, GuoLM, ZhouHK, et al.. Using drugs to target necroptosis: dual roles in disease therapy. Histol Histopathol, 2018, 33(8): 773-789

[103] YanWT, LuS, YangYD, et al.. Research trends, hot spots and prospects for necroptosis in the field of neuroscience. Neural Regen Res, 2021, 16(8): 1628-1637

[104] ZhangQ, WanXX, HuXM, et al.. Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases. Front Cell Dev Biol, 2021, 9: 809656

[105] YanWT, YangYD, HuXM, et al.. Do pyroptosis, apoptosis, and necroptosis (PANoptosis) exist in cerebral ischemia? Evidence from cell and rodent studies. Neural Regen Res, 2022, 17(8): 1761-1768

[106] HorvathC, YoungM, JarabicovaI, et al.. Inhibition of Cardiac RIP3 Mitigates Early Reperfusion Injury and Calcium-Induced Mitochondrial Swelling without Altering Necroptotic Signalling. Int J Mol Sci, 2021, 22(15): 7983

[107] ZhangT, ZhangY, CuiM, et al.. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress- induced myocardial necroptosis. Nat Med, 2016, 22(2): 175-182

[108] SheL, TuH, ZhangYZ, et al.. Inhibition of Phosphoglycerate Mutase 5 Reduces Necroptosis in Rat Hearts Following Ischemia/Reperfusion Through Suppression of Dynamin-Related Protein 1. Cardiovasc Drugs Ther, 2019, 33(1): 13-23

[109] ZhuP, HuS, JinQ, et al.. Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway. Redox Biol, 2018, 16: 157-168

[110] ZhuP, WanK, YinM, et al.. RIPK3 Induces Cardiomyocyte Necroptosis via Inhibition of AMPK-Parkin-Mitophagy in Cardiac Remodelling after Myocardial Infarction. Oxid Med Cell Longev, 2021, 2021: 6635955

[111] BerkhemerOA, FransenPS, BeumerD, et al.. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med, 2015, 372(1): 11-20

[112] JovinTG, ChamorroA, CoboE, et al.. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med, 2015, 372(24): 2296-2306

[113] BakerTS, RobenyJ, CruzD, et al.. Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review. Front Neurol, 2021, 12: 753182

[114] XieQ, ZhangL, XieL, et al.. Z-ligustilide: A review of its pharmacokinetics and pharmacology. Phytother Res, 2020, 34(8): 1966-1991

[115] MondalNK, BeheraJ, KellyKE, et al.. Tetrahydrocurcumin epigenetically mitigates mitochondrial dysfunction in brain vasculature during ischemic stroke. Neurochem Int, 2019, 122: 120-138

[116] DiY, HeYL, ZhaoT, et al.. Methylene Blue Reduces Acute Cerebral Ischemic Injury via the Induction of Mitophagy. Mol Med, 2015, 21(1): 420-429